BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Linifanib

0+ PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Linifanib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

foretinib
80 shared targets
ast
83 shared targets
quizartinib
44 shared targets
vandetanib
52 shared targets
doramapimod
47 shared targets
cediranib
45 shared targets
defosbarasertib
39 shared targets
rebastinib
49 shared targets
tandutinib
32 shared targets
pazopanib
44 shared targets
Loading evidence profile...

This evidence profile for Linifanib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.